MAVS Antikörper (N-Term) (Cy3)
Kurzübersicht für MAVS Antikörper (N-Term) (Cy3) (ABIN8010620)
Target
Alle MAVS Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Verwendungszweck
- Anti-MAVS Antibody Cy3 Conjugated
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins.
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- A synthetic peptide corresponding to a sequence at N-terminus of human MAVS.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Flow Cytometry, 1-3 μg/1x106 cells
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Haltbarkeit
- 12 months
-
-
- MAVS (Mitochondrial Antiviral Signaling Protein (MAVS))
-
Andere Bezeichnung
- MAVS
-
Hintergrund
-
Background: Mitochondrial antiviral-signaling protein (MAVS) is a protein that in humans is encoded by the MAVS gene. The protein is also known by the names VISA (virus-induced signaling adapter), IPS-1 and Cardif. This gene encodes an intermediary protein necessary in the virus-triggered beta interferon signaling pathways. It is required for activation of transcription factors which regulate expression of beta interferon and contributes to antiviral immunity.
Gene Full Name: mitochondrial antiviral signaling protein
-
Gen-ID
- 57506
-
UniProt
- Q7Z434
-
Pathways
- Activation of Innate immune Response, Inositol Metabolic Process, Hepatitis C
Target
-